AIDS and Behavior

, Volume 11, Issue 5, pp 652–662

Safe Syringe Disposal is Related to Safe Syringe Access among HIV-positive Injection Drug Users

  • Phillip O. Coffin
  • Mary H. Latka
  • Carl Latkin
  • Yingfeng Wu
  • David W. Purcell
  • Lisa Metsch
  • Cynthia Gomez
  • Marc N. Gourevitch
  • INSPIRE Study Group
Original Paper

DOI: 10.1007/s10461-006-9171-x

Cite this article as:
Coffin, P.O., Latka, M.H., Latkin, C. et al. AIDS Behav (2007) 11: 652. doi:10.1007/s10461-006-9171-x

Abstract

We evaluated the effect of syringe acquisition on syringe disposal among HIV-positive injection drug users (IDUs) in Baltimore, New York City, and San Francisco (N = 680; mean age 42 years, 62% male, 59% African-American, 21% Hispanic, 12% White). Independent predictors of safe disposal were acquiring syringes through a safe source and ever visiting a syringe exchange program. Weaker predictors included living in San Francisco, living in the area longer, less frequent binge drinking, injecting with an HIV+ partner, peer norms supporting safe injection, and self-empowerment. Independent predictors of safe “handling”—both acquiring and disposing of syringes safely—also included being from New York and being older. HIV-positive IDUs who obtain syringes from a safe source are more likely to safely dispose; peer norms contribute to both acquisition and disposal. Interventions to improve disposal should include expanding sites of safe syringe acquisition while enhancing disposal messages, alternatives, and convenience.

Keywords

Injection drug user HIV Hepatitis C Syringe exchange Syringe disposal 

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Phillip O. Coffin
    • 1
  • Mary H. Latka
    • 1
  • Carl Latkin
    • 2
  • Yingfeng Wu
    • 1
  • David W. Purcell
    • 3
  • Lisa Metsch
    • 4
  • Cynthia Gomez
    • 5
  • Marc N. Gourevitch
    • 6
  • INSPIRE Study Group
  1. 1.Center for Urban Epidemiologic StudiesNew York Academy of MedicineNew YorkUSA
  2. 2.Johns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.National Center for HIV, STD, TB Prevention, Division of HIV/AIDS Prevention, Centers for Disease Control and PreventionAtlantaUSA
  4. 4.Department of Epidemiology and Public Health, Comprehensive Drug Research CenterUniversity of Miami School of MedicineMiamiUSA
  5. 5.Center for AIDS Prevention StudiesUniversity of California, San FranciscoSan FranciscoUSA
  6. 6.Division of General Internal Medicine, Department of MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations